A cohort study on Bevacizumab in patients with advansed non-small-cell lung cancer excluding squamous cell lung cancer
Phase 4
- Conditions
- non-small-cell lung cancer(Excluding squamous call lung cancer)
- Registration Number
- JPRN-UMIN000006717
- Lead Sponsor
- Ibaraki respiratory tract tumor study group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 200
Inclusion Criteria
Not provided
Exclusion Criteria
None.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method